Methacrylic Acid
Excipient (pharmacologically inactive substance)
What is it?
Methacrylic acid is the parent or precursor compound for many ester products used in pharmaceutical manufacturing, such as methacrylic acid coploymer. Many of the final ester compounds are used as excipients in manufacture of enteric coatings and delayed-release products.[1]
[1] Dow Chemicals. Methacrylic acid esters: Background Information. Accessed 8/15/2012. http://www.dow.com/assets/attachments/business/pmat/methacrylate_esters_background_information.pdf
Top Medications with this excipient
- Aspirin 81 mg (Geri-Care)
- Bupropion Hydrochloride Extended-Release (XL) 150 mg (Actavis)
- Bupropion Hydrochloride Extended-Release (XL) 300 mg (Actavis)
- Diclofenac Sodium Delayed Release 75 mg (UDL Laboratories Inc)
- Diclofenac Sodium Delayed Release 50 mg (UDL Laboratories Inc)
- Divalproex Sodium Delayed-Release 250 mg (Zydus Pharmaceuticals)
- Divalproex Sodium Delayed-Release 500 mg (Zydus Pharmaceuticals)
- Divalproex Sodium Delayed-Release (Sprinkle) 125 mg (Zydus Pharmaceuticals)
- Entocort EC 3 mg (Prometheus Laboratories Inc.)
- Lamictal XR 300 mg (GlaxoSmithKline)
- Lamictal XR 200 mg (GlaxoSmithKline)
- Naproxen Enteric Coated 500 mg (Sandoz Pharmaceuticals Inc.)
- Nexium 40 mg (AstraZeneca Pharmaceuticals)
- Omeprazole 20 mg (Mylan Pharmaceuticals Inc.)
- Omeprazole Delayed Release 40 mg (Mylan Pharmaceuticals Inc.)
- Oxybutynin Chloride Extended Release 10 mg (Teva Pharmaceuticals USA)
- Oxybutynin Chloride Extended Release 15 mg (Teva Pharmaceuticals USA)
- Oxybutynin Chloride Extended Release 5 mg (Teva Pharmaceuticals USA)
- Tamsulosin Hydrochloride 0.4 mg (Zydus Pharmaceuticals)
- Vimovo esomeprazole 20 mg / naproxen 500 mg (AstraZeneca Pharmaceuticals)
